A Pilot Return-to-Work Cognitive Intervention After Stroke
Launched by NATIONAL UNIVERSITY OF SINGAPORE · Aug 4, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new program designed to help people who have had a stroke get back to work. Even after physical recovery, many stroke survivors find it hard to return to their jobs because of ongoing thinking and memory problems. This study offers a community-based brain health program that focuses on improving thinking skills and work-related abilities. Caregivers, who provide important support, will also be involved in the program. The study will look at whether the program is practical and well-received, and whether it helps improve thinking, return-to-work success, mental health, energy levels, and self-care.
People who might join this study are stroke survivors aged 21 to 65 who live at home, are at least three months post-stroke, and want to return to work or find a new job. Participants should be able to understand and speak English, have mild thinking difficulties after their stroke, and be able to take part in cognitive activities without major speech or physical problems. Caregivers who live with or know the stroke survivor well and meet similar consent and language requirements can also join. Participants can expect to take part in brain training activities and assessments, and their progress will be monitored throughout the program. This study has not started recruiting yet but aims to fill an important gap in stroke recovery support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria (for stroke survivors):
- • Between 21 to 65 years old
- • Ability to provide informed consent
- • Consent to recording / photo-taking
- • Living in the community with at least three months after stroke
- • Looking to return to work or switch jobs after stroke
- • No significant aphasia or physical disability issues which will impede them from performing cognitive tasks in the interventions and assessments
- • No major psychiatric illnesses
- • Able to understand and converse in English
- • Score on MoCA ≤22 and/or SDMT ≤13 (for those educated ≤6 years) or SDMT ≤32 (for those educated \>6 years)
- • Meet criteria for Mild Cognitive Impairment based on the Vascular Dementia Battery
- Inclusion Criteria (for caregivers):
- • At least 21 years old
- • Ability to provide informed consent
- • Consent to recording / photo-taking
- • Staying with or having knowledge of the stroke survivor's functioning
- • No major psychiatric illnesses
- • Able to understand and converse in English
- Exclusion Criteria (for stroke survivors):
- • Less than 21 years old
- • More than 65 years old
- • Unable to provide informed consent
- • Refuse recording
- • Not living in the community and having less than three months after stroke
- • Significant aphasia or physical disability issues which will impede them from performing cognitive tasks in the interventions and assessments
- • Major psychiatric illnesses
- • Not able to understand and converse in English
- Exclusion Criteria (for caregivers):
- • Less than 21 years old
- • Unable to provide informed consent
- • Refuse recording
- • Not staying with or not having knowledge of the stroke survivor's functioning
- • Major psychiatric illnesses
- • Not able to understand and converse in English
About National University Of Singapore
The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported